Measuring body composition (fat versus lean mass) should become routine in the management of patients on GLP-1 medications. The Takeaway While GLP-1 medications are effective for weight loss, rapid weight reduction can lead to significant loss of fat-free mass, including muscle
received honoraria for speaking at meetings from Novartis, Sanofi, Lilly, Astrazeneca, and NovoNordisk
In a future TNG post, contributing writer MacKenzie Isaac, a doctoral student in population health, will cover equity issues surrounding GLP-1 RA access
In contrast, when analyzing stroke outcomes, the effect was more pronounced with GLP-1 RAs, which provided the greatest contribution to the reduction of stroke events
These have been widely tested and shown to be safe for this purpose
Still being determined through ongoing trials